Clinical Trial Update: Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial [NA]

View source ↗

Summary

This update describes a single-center, open-label randomized trial comparing neoadjuvant CAPEOX chemotherapy to upfront surgery for locally advanced colon cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Minimal Residual Disease, Immunoscore | NA | Status: NOT_YET_RECRUITING